V. Goel

发表

Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma.

Carlos Cuevas, Paolo P. Provenzano, Paolo P Provenzano, 2012, Cancer cell.

Genetic Interaction Between NRAS and BRAF Mutations and PTEN / MMAC 1 Inactivation in Melanoma

F. Haluska, Guang Yang, H. Tsao, 2010 .

Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice

N. Ibrahim, S. Westmoreland, F. Haluska, 2009, Oncogene.

Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition.

P. A. Thompson, C. Stumpf, Qing Han, 2018, Journal of medicinal chemistry.

eFT508, a Potent and Selective Mitogen-Activated Protein Kinase Interacting Kinase (MNK) 1 and 2 Inhibitor, Is Efficacious in Preclinical Models of Diffuse Large B-Cell Lymphoma (DLBCL)

P. A. Thompson, K. Webster, Katti A. Jessen, 2015 .

Abstract 596: eFT508, a potent and highly selective inhibitor of MNK1/2 regulates immune checkpoint and cytokine expression promoting anti-tumor immunity

P. A. Thompson, C. Stumpf, K. Webster, 2017 .

Abstract PR11: eFT508: An oral, potent and highly selective inhibitor of MNK1 and MNK2, promotes anti-tumor immunity as a monotherapy and in combination with immune checkpoint blockade

P. A. Thompson, C. Stumpf, K. Webster, 2017 .

Zotatifin, an eIF4A-Selective Inhibitor, Blocks Tumor Growth in Receptor Tyrosine Kinase Driven Tumors

P. A. Thompson, C. Stumpf, K. Webster, 2021, Frontiers in Oncology.

Genetic Alterations in Signaling Pathways in Melanoma

F. Haluska, H. Tsao, V. Goel, 2006, Clinical Cancer Research.

PTEN signaling pathways in melanoma

F. Haluska, V. Goel, Heng Wu, 2003, Oncogene.

A Role for ATF2 in Regulating MITF and Melanoma Development

L. Chin, N. Jones, S. Krajewski, 2010, PLoS genetics.

Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.

F. Haluska, Guang Yang, H. Tsao, 2004, The Journal of investigative dermatology.

Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma.

C. Warneke, F. Haluska, M. Redston, 2006, The Journal of investigative dermatology.

Pancreatic Ductal Adenocarcinoma Contains an Effector and Regulatory Immune Cell Infiltrate that Is Altered by Multimodal Neoadjuvant Treatment

S. Riddell, C. Yee, M. Yeh, 2014, PloS one.

Band 3 is a host receptor binding merozoite surface protein 1 during the Plasmodium falciparum invasion of erythrocytes

Steven S. Oh, A. Chishti, Shih-Chun Liu, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Erythrocyte calpain is dispensable for malaria parasite invasion and growth.

Steven S. Oh, A. Chishti, V. Goel, 2002, Molecular and biochemical parasitology.